| FORM
3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF
SECURITIES
Filed pursuant to Section 16(a) of the
Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act
of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0104 |
| Expires: |
December 31, 2014 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person
*
| 1400 FOUNTAINGROVE PARKWAY |
|
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year)
02/07/2018
|
3. Issuer Name
and
Ticker or Trading Symbol
Keysight Technologies, Inc.
[
KEYS
]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
|
10% Owner |
| X |
Officer (give title below) |
|
Other (specify below) |
| SVP |
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check
Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting
Person |
|
| Table I - Non-Derivative Securities Beneficially Owned |
|---|
| 1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
|
Common Stock
|
24,766
|
D
|
|
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
|
Employee Stock Option (Right to Buy)
(1)
|
11/18/2010 |
11/17/2019 |
Common Stock
|
16,519
|
16.42
|
D
|
|
|
Employee Stock Option (Right to Buy)
(1)
|
11/17/2011 |
11/16/2020 |
Common Stock
|
13,618
|
19.62
|
D
|
|
|
Employee Stock Option (Right to Buy)
(1)
|
11/17/2012 |
11/16/2021 |
Common Stock
|
14,832
|
20.74
|
D
|
|
|
Employee Stock Option (Right to Buy)
(1)
|
11/21/2013 |
11/20/2022 |
Common Stock
|
16,512
|
19.97
|
D
|
|
|
Employee Stock Option (Right to Buy)
(1)
|
11/20/2014 |
11/19/2023 |
Common Stock
|
11,854
|
29.83
|
D
|
|
|
Employee Stock Option (Right to Buy)
(1)
|
11/18/2015 |
11/17/2024 |
Common Stock
|
13,683
|
31
|
D
|
|
| Explanation of Responses: |
|
|
|
Jeffrey K. Li, Attorney-in-fact for Mark Pierpoint |
02/09/2018 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
POWER OF ATTORNEY
Know all by these presents that the undersigned hereby constitutes and appoints
Stephen Williams and Jeffrey Li, and each of them, signing singly,
his true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned?s capacity
as an officer of Keysight Technologies, Inc., Forms 3, 4 and 5 and Form ID in
accordance with Section 16(a) of the Securities Exchange Act of 1934, as
amended (the ?Exchange Act?), and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete the execution of any such
Form 3, Form 4, Form 5 or Form ID and the timely filing of such form with
the United States Securities and Exchange Commission and any stock
exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of
benefit to, in the best interest of, or legally required by, the undersigned,
it being understood that the documents executed by such attorney-in-fact on
behalf of the undersigned, pursuant to this Power of Attorney shall be in
such form and shall contain such terms and conditions as such
attorney-in-fact may approve in his or her discretion.
The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform all and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as
such attorney-in-fact might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or his or her substitute or substitutes, shall lawfully
do or cause to be done by virtue of his or her Power of Attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving such capacity at the request of the
undersigned, are not assuming, nor is Keysight Technologies assuming, any of
the undersigned?s responsibilities to comply with Section 16 of the
Exchange Act.
This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4 and 5 and Form ID
with respect to the undersigned?s holdings of, and transactions in, securities
issued by Keysight Technologies unless earlier revoked by the undersigned in
a signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 5th day of February, 2018.
/s/ Mark Pierpoint
Mark Pierpoint
